FLUZONE HD TIV SH 2026

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 49281-016
  • Package NDC 49281-016-50
  • Application number BLA103914
  • SPL ID 602db593-4e91-45de-ac0f-6a8b0312341a

What the source publishes

Labeler
Sanofi Vaccines US Inc.
Active ingredients
INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)
Form
INJECTION, SUSPENSION
Routes
INTRAMUSCULAR
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
VACCINE

Names this record is found by

Complete source data
us:fda:ndc:49281-016_602db593-4e91-45de-ac0f-6a8b0312341a
{
  "name": "FLUZONE HD TIV SH 2026",
  "splId": "602db593-4e91-45de-ac0f-6a8b0312341a",
  "labels": [],
  "routes": [
    "INTRAMUSCULAR"
  ],
  "labeler": "Sanofi Vaccines US Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 SYRINGE, GLASS in 1 PACKAGE (49281-016-50)  / .5 mL in 1 SYRINGE, GLASS (49281-016-88)",
      "package_ndc": "49281-016-50",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20261231",
      "marketing_start_date": "20260220"
    }
  ],
  "productId": "49281-016_602db593-4e91-45de-ac0f-6a8b0312341a",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SUSPENSION",
  "productNdc": "49281-016",
  "deaSchedule": null,
  "genericName": "INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)",
  "productType": "VACCINE",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": "20261231",
  "activeIngredients": [
    {
      "name": "INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "60 ug/.5mL"
    },
    {
      "name": "INFLUENZA A VIRUS A/SINGAPORE/GP20238/2024 IVR-277 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "60 ug/.5mL"
    },
    {
      "name": "INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "60 ug/.5mL"
    }
  ],
  "applicationNumber": "BLA103914",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260220",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "unknown",
  "harmonizedIdentifiers": {},
  "listingExpirationDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:49281-016_602db593-4e91-45de-ac0f-6a8b0312341a"